Transcellular signaling and pharmacological modulation of thrombin- induced production of plasminogen activator inhibitor-1 in vascular smooth muscle cells

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue 2, 1998, Pages 151-156

  Shen, Garry X ^a   Ren, Song ^a   Fenton II, John W ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b WADSWORTH CENTER   (United States)

Author keywords

Hirulog; Plasminogen activator inhibitor 1; Smooth muscle cells; Thrombin; Transcellular signaling

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HIRULOG; MESSENGER RNA; PHOSPHOLIPASE C; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; THROMBIN; THROMBIN RECEPTOR;

ANIMAL CELL; BABOON; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0031943701     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995834     Document Type: Conference Paper

References (29)

1. Fenton JW II, Ofosu FA, Brezniak DV, Hassouna HI. Understanding thrombin and hemostasis. Hematol/Oncol Clin North Am 1993;7:1107-1109
2. Suksela O, Rifkin DB. Cell-associated plasminogen activation: Regulation and physiological functions. Annu Rev Cell Biol 1988;4:93-126
3. Hamsten A, Wiman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985;313:1557-1563
4. Francis RB Jr, Kawanishi D, Baruch T, Mahrer P, Rahimtoola S, Feinstein DI. Impaired fibrinolysis in coronary artery disease. Am Heart J 1988;115:776-780
5. Sakata K, Kurata C, Taguchi T, et al. Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia. Am Heart J 1990;120:831-838
6. Cortellaro M, Cofrancesco E, Boschetti C, et al. Increased fibrin turnover and high PAI-1 activity as predictor of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group. Arteriosclerosis Thromb 1993;13:1412-1417
7. Yorimuitsu K, Saito T, Toyozaki T, Ishide T, Ohnama N, Inagaki Y. Immunohistochemical localization of plasminogen activator inhibitor-1 in human coronary atherosclerotic lesions involved in acute myocardial infarction. Heart Vessel 1993;8:160-162
8. Grülich-Henn J, Müller-Berghaus G. Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 by diacylglycerol, phorbol ester, and thrombin. Blut 1990;61:38-44
9. He C-J, Peralsi MN, Rebibou JM, Meulders Q, Sraer JD, Rondeau E. Thrombin signal transduction mechanisms in human glomerular epithelial cells. J Cell Physiol 1992;150:475-483
10. Noda-Heiny H, Fujii S, Sobel BE. Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin. Circ Res 1993;72:36-43
11. Wojta J, Gallicchio M, Zoellner H, et al. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb Haemostas 1993;70:469-474
12. Cockell KA, Ren S, Sun J, Angel A, Shen GX. Effect of thrombin on release of plasminogen activator inhibitor-1 from cultured primate arterial smooth muscle cells. Thromb Res 1995;77: 119-131
13. Au YPT, Kenagy RD, Clowes AW. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J Biol Chem 1991;267:3438-3444
14. Fenton JW II, Fasco MJ, Stackrow AB, Aronson DL, Young AM, Finlayson JS. Human thrombins. Production, evaluation, and properties of α-thrombin. J Biol Chem 1977;252:3587-3598
15. Bing DH, Cory M, Fenton JW II. Exosite affinity labelling of human thrombins. Similar labelling on the A chain and B chain/ fragments of clotting α- and nonclotting α/β-thrombins. J Biol Chem 1977;252:8027-8034
16. Beecher KL, Anderson TT, Fenton JW II, Festoff BW. Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J Neurosci Res 1994;37:108-115
17. Shen X-Y, Hamilton TA, DiCorleto PE. Lipopolysaccharide-induced expression of the competence gene KC in vascular endothelial cells is mediated through protein kinase C. J Cell Physiol 1989;140:44-51
18. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5924-5929
19. Southern E. Detection of specific sequences among DNA region of the thrombin receptor resembling hirudin binds to thrombin and alters enzymatic specificity. J Molec Biol 1975;98:503-517
20. Wun T-C, Kretzmer KK. cDNA cloning and expression in E. coli of a plasminogen activator (PAI) related to a PAI produced by HepG2 hepatoma cell. FEBS Lett 1987;210:11-16
21. 2+ release. J Biol Chem 1992;267:7295-7302
22. Ren S, Cockell KA, Fenton JW II, Angel A, Shen GX. G proteins and phospholipase C mediate thrombin-induced generation of plasminogen activator inhibitor-1 from vascular smooth muscle cells. J Vasc Res 1997;34:82-89
23. van Hinsbergh VW, Vermeer M, Koolwijk P, Grimbergh J, Koostra T. Genistein reduces tumor necrosis factor α-induced plasminogen activator inhibitor-1 transcription hut not urokinase expression in human endothelial cells. Blood 1994;84:2984-2991
24. Francis RB Jr, Neely S. Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP. Biochim Biophys Acta 1989;1012:207-213
25. Fenton JW II. Leeches to hirulogs and other thrombin-directive antithrombotics. Hemotol/Oncol Clin North Am 1992;6:1121-1129
26. Maraganore JM, Bourdon P, Jablonski J, Ramachandran KL, Fenton JW II. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 1990;31:7095-7101
27. Fenton JW II, Ni F, Witting JI, Brezniak DV, Anderson TT, Malik AB. The rational design of thrombin-directed antithrombotics. Adv Exp Med Biol 1993;340:1-13
28. Bittl JA. Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplasty. The Hirulog Angioplasty Study Investigators. Am Heart J 1995;130:658-665
29. Theroux P, Perez-Villa F, Waters D, Lesperance J, Shabani F, Bonan R. Randomized double-blind comparison of two doses of hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction. Circulation 1995;91:2132-2139